Relationship of DUX4 and target gene expression in FSHD myocytes. Issue 4 (4th February 2021)

• Record Type: Journal Article
• Authors: Chau, Jonathan; Kong, Xiangduo; Viet Nguyen, Nam; Williams, Katherine; Ball, Miya; Tawil, Rabi; Kiyono, Tohru; Mortazavi, Ali; Yokomori, Kyoko
• Is Part Of: Human mutation. Volume 42:Issue 4(2021)
• Page Start: 421
• Page End: 433
• Publication Date: 2021-02-04
• Subjects: DUX4 -- FSHD -- KDM4E -- LEUTX -- RNAScope -- skeletal myotubes; Human chromosome abnormalities -- Periodicals; Mutation (Biology) -- Periodicals; 616.04205
• DOI: 10.1002/humu.24171
• Languages: English
• ISSNs: 1059-7794

Abstract

Abstract: Facioscapulohumeral dystrophy (FSHD) is associated with the upregulation of the DUX4 transcription factor and its target genes. However, low‐frequency DUX4 upregulation in patient myocytes is difficult to detect and examining the relationship and dynamics of DUX4 and target gene expression has been challenging. Using RNAScope in situ hybridization with highly specific probes, we detect the endogenous DUX4 and target gene transcripts in situ in patient skeletal myotubes during 13‐day differentiation in vitro. We found that the endogenous DUX4 transcripts primarily localize as foci in one or two nuclei as compared with the accumulation of the recombinant DUX4 transcripts in the cytoplasm. We also found the continuous increase of DUX4 and target gene‐positive myotubes after Day 3, arguing against its expected immediate cytotoxicity. Interestingly, DUX4 and target gene expression become discordant later in differentiation with the increase of DUX4 ‐positive/target gene‐negative as well as DUX4 ‐negative/target gene‐positive myotubes. Depletion of DUX4‐activated transcription factors, DUXA and LEUTX, specifically repressed a DUX4‐target gene, KDM4E, later in differentiation, suggesting that after the initial activation by DUX4, target genes themselves contribute to the maintenance of downstream gene expression. Together, the study provides important new insights into the dynamics of the DUX4 transcriptional network in FSHD patient myocytes.